2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Schiff Andrew N | 10% Owner | 10,100,000 | Jul 15, 2019 |
| Elms Steve | 10% Owner | 10,100,000 | Jul 15, 2019 |
| Aisling Capital IV, LP | 10% Owner | 10,100,000 | Jul 15, 2019 |
| Aisling Capital Partners IV LLC | 10% Owner | 10,100,000 | Jul 15, 2019 |
| Aisling Capital Partners IV, LP | 10% Owner | 10,100,000 | Jul 15, 2019 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Nov 27, 2024 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 25, 2024 | Nov 27, 2024 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 25, 2024 | Sep 12, 2024 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 25, 2024 | Sep 12, 2024 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Borellini Flavia | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Chung Jane | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Murphy Samuel Lafayette | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | DARCY THOMAS E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Simon Barry J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Barlow Jane F | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Rubino Stephen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2024 | May 29, 2024 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2024 | May 29, 2024 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 14, 2024 | May 16, 2024 | Faerm Michael E. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 16, 2024 | Faerm Michael E. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 22, 2024 | Burcar Melody | Senior VP, Finance | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 12, 2024 | Mar 13, 2024 | Rothera Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 12, 2024 | Mar 13, 2024 | Cohen Darrel P. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 12, 2024 | Mar 13, 2024 | Chevallard Daniel R. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2024 | Feb 27, 2024 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2024 | Feb 27, 2024 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2024 | Feb 27, 2024 | Chevallard Daniel R. | CFO | Sell | 47.5 | -3,405 | -3.22% | ✗ | $2.5K |
| Nov 30, 2023 | Dec 4, 2023 | Rothera Mark | CEO | Buy | 91.3 | +100,000 | 100.00% | ✗ | $49.4K |
| Nov 25, 2023 | Nov 28, 2023 | Chevallard Daniel R. | CFO | Sell | 47.5 | -3,720 | -3.63% | ✗ | $1.9K |
| Nov 25, 2023 | Nov 28, 2023 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 25, 2023 | Nov 28, 2023 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 25, 2023 | Aug 29, 2023 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 25, 2023 | Aug 29, 2023 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 25, 2023 | Aug 29, 2023 | Chevallard Daniel R. | CFO | Sell | 47.5 | -3,512 | -3.54% | ✗ | $5.1K |
| Aug 16, 2023 | Aug 18, 2023 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 16, 2023 | Aug 18, 2023 | Cohen Darrel P. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 16, 2023 | Cohen Darrel P. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 8, 2023 | Jun 9, 2023 | Simon Barry J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 9, 2023 | Rubino Stephen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 9, 2023 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 9, 2023 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 9, 2023 | Murphy Samuel Lafayette | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 9, 2023 | DARCY THOMAS E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 9, 2023 | Chung Jane | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 9, 2023 | Borellini Flavia | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 9, 2023 | Barlow Jane F | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | Chevallard Daniel R. | CFO | Sell | 47.5 | -3,635 | -3.79% | ✗ | $5.2K |
| Mar 16, 2023 | Mar 17, 2023 | Rothera Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 16, 2023 | Mar 17, 2023 | Rojkjaer Lisa | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 16, 2023 | Mar 17, 2023 | Chevallard Daniel R. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2023 | Feb 28, 2023 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2023 | Feb 28, 2023 | Rojkjaer Lisa | Chief Medical Officer | Sell | 47.5 | -2,156 | -4.29% | ✗ | $3.6K |
| Feb 25, 2023 | Feb 28, 2023 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2023 | Feb 28, 2023 | Chevallard Daniel R. | CFO | Sell | 47.5 | -3,599 | -3.89% | ✗ | $6.1K |
| Nov 25, 2022 | Nov 29, 2022 | Chevallard Daniel R. | CFO | Sell | 47.5 | -3,532 | -3.96% | ✗ | $9.6K |
| Nov 25, 2022 | Nov 29, 2022 | Rojkjaer Lisa | Chief Medical Officer | Sell | 47.5 | -2,116 | -4.39% | ✗ | $5.8K |
| Nov 25, 2022 | Nov 29, 2022 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 25, 2022 | Nov 29, 2022 | ROYSTON IVOR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 19, 2022 | Sep 19, 2022 | Rothera Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 19, 2022 | Rothera Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 25, 2022 | Aug 29, 2022 | Rojkjaer Lisa | Chief Medical Officer | Sell | 47.5 | -2,190 | -4.73% | ✗ | $8.8K |
| Aug 25, 2022 | Aug 29, 2022 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 25, 2022 | Aug 29, 2022 | Chevallard Daniel R. | CFO | Sell | 46.3 | -3,655 | -4.25% | ✗ | $14.7K |
| Aug 25, 2022 | Aug 29, 2022 | ROYSTON IVOR | CEO | Sell | 42.5 | -13,379 | -2.08% | ✗ | $53.7K |
| Aug 10, 2022 | Aug 11, 2022 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 10, 2022 | Aug 11, 2022 | Chung Jane | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 11, 2022 | Chung Jane | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 9, 2022 | Jun 10, 2022 | Simon Barry J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Rubino Stephen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | ONETTO NICOLE | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Murphy Samuel Lafayette | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Huang Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | DARCY THOMAS E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Borellini Flavia | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Barlow Jane F | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2022 | May 27, 2022 | ROYSTON IVOR | CEO | Sell | 46.3 | -13,162 | -2.08% | ✗ | $25K |
| May 25, 2022 | May 27, 2022 | Rojkjaer Lisa | Chief Medical Officer | Sell | 47.5 | -2,154 | -4.86% | ✗ | $4.1K |
| May 25, 2022 | May 27, 2022 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2022 | May 27, 2022 | Chevallard Daniel R. | CFO | Sell | 47.5 | -3,596 | -4.35% | ✗ | $6.8K |
| Mar 17, 2022 | Mar 18, 2022 | Chevallard Daniel R. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 17, 2022 | Mar 18, 2022 | Rojkjaer Lisa | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 17, 2022 | Mar 18, 2022 | ROYSTON IVOR | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2022 | Mar 1, 2022 | ROYSTON IVOR | CEO | Sell | 46.3 | -14,635 | -2.35% | ✗ | $40.7K |
| Feb 25, 2022 | Mar 1, 2022 | Rojkjaer Lisa | Chief Medical Officer | Sell | 47.5 | -2,395 | -5.62% | ✗ | $6.7K |
| Feb 25, 2022 | Mar 1, 2022 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2022 | Mar 1, 2022 | Chevallard Daniel R. | CFO | Sell | 46.3 | -3,998 | -5.01% | ✗ | $11.1K |
| Dec 29, 2021 | Dec 30, 2021 | ROYSTON IVOR | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 25, 2021 | Nov 29, 2021 | Pomerantz Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 25, 2021 | Nov 29, 2021 | Rojkjaer Lisa | Chief Medical Officer | Sell | 46.3 | -4,541 | -10.56% | ✗ | $21.8K |
| Nov 25, 2021 | Nov 29, 2021 | Chevallard Daniel R. | CFO | Sell | 46.3 | -7,579 | -9.41% | ✗ | $36.5K |
| Nov 25, 2021 | Nov 29, 2021 | ROYSTON IVOR | CEO | Sell | 42.5 | -27,747 | -4.49% | ✗ | $133.5K |
| Nov 15, 2021 | Nov 15, 2021 | ROYSTON IVOR | CEO | Buy | 78.8 | +8,000 | 1.43% | ✗ | $44.5K |
| Sep 28, 2021 | Sep 29, 2021 | Chevallard Daniel R. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 16, 2021 | Aug 17, 2021 | Borellini Flavia | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 16, 2021 | Aug 17, 2021 | Barlow Jane F | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 17, 2021 | Borellini Flavia | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 17, 2021 | Barlow Jane F | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 28, 2021 | Jun 1, 2021 | Chevallard Daniel R. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 11, 2021 | May 13, 2021 | Rojkjaer Lisa | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 26, 2021 | Mar 30, 2021 | Rojkjaer Lisa | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |